Skip to main content
. 2017 Nov 27;8(65):109289–109300. doi: 10.18632/oncotarget.22672

Figure 2. APRIL, BCMA and TACI expression in lung cancer.

Figure 2

(A) Relative mRNA expression of APRIL, BCMA and TACI in NSCLC tissues. (B, C) Western blot results of APRIL and its reporters in NSCLC tissues. (D) Relative APRIL, BCMA and TACI mRNA expression in three lung cancer cell lines (A549, H1650 and H1299). (E) Western blot analysis of cell lysates showing protein levels of APRIL, BCMA and TACI. (F) A549 cells were stimulated with EGF or BDNF. qRT-PCR analysis shows APRIL, BCMA and TACI mRNA levels. Values were mean ± SD (n = 3 independent experiments). * stands for significant difference (p< 0.05)